Skip to content

24-Hour Intralocular Pressure Monitoring of habitual position in Glaucoma or Ocular Hypertension Patient

24-Hour Intralocular Pressure Monitoring of habitual position in Glaucoma or Ocular Hypertension Patient - 24-Hour Intralocular Pressure Monitoring of habitual position in Glaucoma or Ocular Hypertension Patient

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073216
Enrollment
Unknown
Registered
2023-07-04
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

Observation group:N/A

Sponsors

Beijing Tongren Hospital, Capital Medical university, Beijing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The POAG inclusion criteria were defined as follows: (1) normal anterior chamber and open angle by gonioscopy examination (2) IOP greater than 21 mmHg on 2 or more occasions in one or both eyes (3) characteristic glaucomatous optic disc damage, and visual field (VF) defects (4) binocular vision better than 20/40. Subjects with OHT are also included. OHT is defined as: (1) consistently elevated IOP greater than 21mmHg on 2 or more occasions in one or both eyes (2) in the absence of clinical evidence of optic nerve damage, VF defect or other unknown pathology.

Exclusion criteria

Exclusion criteria: (1) Previous history of intraocular surgery and / or penetrating ocular trauma (2) Complicated with serious eye diseases, including corneal diseases that can affect the measurement (3) Combined with serious diseases that hinder health, such as severe heart disease, lung, liver and kidney diseases (4) Sleep disorder

Design outcomes

Primary

MeasureTime frame
intraocular pressure;

Countries

China

Contacts

Public ContactShuning Li

Beijing Tongren Hospital, Capital Medical university, Beijing, China

lishuningqd@163.com+86 132 4180 2936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026